Benefit of Bone Drug in Prostate Cancer in Doubt - MedPage Today

USA TODAY

Benefit of Bone Drug in Prostate Cancer in Doubt MedPage Today Amgen would like to expand the indication to make the biologic available as a preventive treatment for men with castrate-resistant prostate cancer at high risk of developing bone metastases. The FDA's Oncologic Drugs Advisory Committee will meet ... FDA questions Amgen drug for prostate cancerUSA TODAY FDA Ponders Cancer Benefits, Risks of Amgen's XgevaInvestor's Business Daily all 222 news articles »

Data Show 15 Percent Drop in Prostate Cancer Deaths - Sacramento Bee

International Business Times

Data Show 15 Percent Drop in Prostate Cancer Deaths Sacramento Bee In the US, a baby boomer turns 50 every 8.5 seconds, making the risk pool for prostate cancer larger and larger. ZERO provides free prostate cancer testing to at-risk men across the country through the Drive Against Prostate Cancer. PSA Testing's Next LeveldailyRx Prostate Cancer Drug: How to Find Clinical Trials of Promising MedInternational Business Times Common genetic variants in prostate cancer risk prediction - results from the ...UroToday Cancer Network all 15 news articles »